1. CPX-351 exhibits potent and direct ex vivo cytotoxicity against AML blasts with enhanced efficacy for cells harboring the FLT3-ITD mutation. (February 2017) Authors: Gordon, Max J.; Tardi, Paul; Loriaux, Marc M.; Spurgeon, Stephen E.; Traer, Elie; Kovacsovics, Tibor; Mayer, Lawrence D.; Tyner, Jeffrey W. Journal: Leukemia research Issue: Volume 53(2017:Feb.) Page Start: 39 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Optimizing Liposomal Cisplatin Efficacy through Membrane Composition Manipulations. (23rd December 2010) Authors: Zisman, Natalia; Dos Santos, Nancy; Johnstone, Sharon; Tsang, Alan; Bermudes, David; Mayer, Lawrence; Tardi, Paul Other Names: Peters G. J. Academic Editor. Journal: Chemotherapy research and practice Issue: Volume 2011(2011) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Passive and semi-active targeting of bone marrow and leukemia cells using anionic low cholesterol liposomes. (20th October 2016) Authors: Tardi, Paul; Wan, Chung Ping Leon; Mayer, Lawrence Journal: Journal of drug targeting Issue: Volume 24:Number 9(2016) Page Start: 797 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗